BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29198053)

  • 21. Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma.
    Maxwell R; Luksik AS; Garzon-Muvdi T; Yang W; Huang J; Bettegowda C; Jallo GI; Terezakis SA; Groves ML
    World Neurosurg; 2018 Nov; 119():e1006-e1015. PubMed ID: 30138731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC).
    Fonseca A; Afzal S; Bowes L; Crooks B; Larouche V; Jabado N; Perreault S; Johnston DL; Zelcer S; Fleming A; Scheinemann K; Silva M; Vanan MI; Mpofu C; Wilson B; Eisenstat DD; Lafay-Cousin L; Hukin J; Hawkins C; Bartels U; Bouffet E
    J Neurooncol; 2020 Aug; 149(1):45-54. PubMed ID: 32632896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma.
    Jackson S; Patay Z; Howarth R; Pai Panandiker AS; Onar-Thomas A; Gajjar A; Broniscer A
    J Neurooncol; 2013 Sep; 114(3):339-44. PubMed ID: 23813229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.
    Kilburn LB; Kocak M; Baxter P; Poussaint TY; Paulino AC; McIntyre C; Lemenuel-Diot A; Lopez-Diaz C; Kun L; Chintagumpala M; Su JM; Broniscer A; Baker JN; Hwang EI; Fouladi M; Boyett JM; Blaney SM
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29090526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.
    Harward S; Harrison Farber S; Malinzak M; Becher O; Thompson EM
    Childs Nerv Syst; 2018 Mar; 34(3):449-455. PubMed ID: 29151166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffuse intrinsic pontine glioma biopsy: a single institution experience.
    Wang ZJ; Rao L; Bhambhani K; Miller K; Poulik J; Altinok D; Sood S
    Pediatr Blood Cancer; 2015 Jan; 62(1):163-5. PubMed ID: 25263768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric brainstem gliomas: new understanding leads to potential new treatments for two very different tumors.
    Green AL; Kieran MW
    Curr Oncol Rep; 2015 Mar; 17(3):436. PubMed ID: 25702179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology.
    Schroeder KM; Hoeman CM; Becher OJ
    Pediatr Res; 2014 Jan; 75(1-2):205-9. PubMed ID: 24192697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma.
    Porkholm M; Valanne L; Lönnqvist T; Holm S; Lannering B; Riikonen P; Wojcik D; Sehested A; Clausen N; Harila-Saari A; Schomerus E; Thorarinsdottir HK; Lähteenmäki P; Arola M; Thomassen H; Saarinen-Pihkala UM; Kivivuori SM
    Pediatr Blood Cancer; 2014 Sep; 61(9):1603-9. PubMed ID: 24692119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?
    El-Khouly FE; Veldhuijzen van Zanten SEM; Santa-Maria Lopez V; Hendrikse NH; Kaspers GJL; Loizos G; Sumerauer D; Nysom K; Pruunsild K; Pentikainen V; Thorarinsdottir HK; Rutkauskiene G; Calvagna V; Drogosiewicz M; Dragomir M; Deak L; Kitanovski L; von Bueren AO; Kebudi R; Slavc I; Jacobs S; Jadrijevic-Cvrlje F; Entz-Werle N; Grill J; Kattamis A; Hauser P; Pears J; Biassoni V; Massimino M; Lopez Aguilar E; Torsvik IK; Joao Gil-da-Costa M; Kumirova E; Cruz-Martinez O; Holm S; Bailey S; Hayden T; Thomale UW; Janssens GOR; Kramm CM; van Vuurden DG
    J Neurooncol; 2019 Oct; 145(1):177-184. PubMed ID: 31522324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances and Clinical Trials Update in the Treatment of Diffuse Intrinsic Pontine Gliomas.
    Dalle Ore C; Coleman C; Gupta N; Mueller S
    Pediatr Neurosurg; 2023; 58(5):259-266. PubMed ID: 36642062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving long-term survival in diffuse intrinsic pontine glioma.
    Felker J; Broniscer A
    Expert Rev Neurother; 2020 Jul; 20(7):647-658. PubMed ID: 32543245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG).
    Gwak HS; Park HJ
    Crit Rev Oncol Hematol; 2017 Dec; 120():111-119. PubMed ID: 29198324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.
    Klimo P; Nesvick CL; Broniscer A; Orr BA; Choudhri AF
    J Neurosurg Pediatr; 2016 Jan; 17(1):57-65. PubMed ID: 26474099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Expression of Wilms' Tumor Protein in Diffuse Intrinsic Pontine Glioma.
    Lee S; Kambhampati M; Yadavilli S; Gordish-Dressman H; Santi M; Cruz CR; Packer RJ; Almira-Suarez MI; Hwang EI; Nazarian J
    J Neuropathol Exp Neurol; 2019 May; 78(5):380-388. PubMed ID: 30990879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.
    Buczkowicz P; Bartels U; Bouffet E; Becher O; Hawkins C
    Acta Neuropathol; 2014 Oct; 128(4):573-81. PubMed ID: 25047029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue sampling in diffuse intrinsic pontine glioma (DIPG) at progression.
    Castañeda Heredia A; Puerta Roldan P; Guillen Quesada A; Sunol Capella M; de Torres Gomez-Pallete C; Muchart J; Cruz Martinez O; Mora J; Morales La Madrid A
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28233413
    [No Abstract]   [Full Text] [Related]  

  • 38. Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry.
    Bartlett AL; Lane A; Chaney B; Escorza NY; Black K; Cochrane A; Minturn J; Bartels U; Warren K; Hansford J; Ziegler D; Diez B; Goldman S; Packer R; Kieran M; DeWire-Schottmiller M; Erker C; Monje-Deisseroth M; Wagner L; Koschmann C; Dorris K; Shih CS; Hassall T; Samson Y; Fisher P; Wang SS; Tsui K; Sevlever G; Zhu X; Dexheimer P; Asher A; Fuller C; Drissi R; Jones B; Leach J; Fouladi M
    Neuro Oncol; 2022 Dec; 24(12):2190-2199. PubMed ID: 35552452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?
    Janssens GO; Kramm CM; von Bueren AO
    J Neurooncol; 2018 Sep; 139(2):501. PubMed ID: 29667083
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular alterations in pediatric brainstem gliomas.
    Porkholm M; Raunio A; Vainionpää R; Salonen T; Hernesniemi J; Valanne L; Satopää J; Karppinen A; Oinas M; Tynninen O; Pentikäinen V; Kivivuori SM
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28792659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.